Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bi mc vc pab mmae ba2679'

Search results for: 'bi mc vc pab mmae ba2679'

Items 1-10 of 136

Page
per page
  1. MC 1046
    A3588 MC 1046
    Summary: Vitamin D3 analog
      Soluble in DMSO
  2. BI 6015
    B5668 BI 6015
    Summary: HNF4α antagonist
      Soluble in DMSO
  3. BI 78D3
    B9011 BI 78D3
    Summary: Competitive JNK inhibitor
      Soluble in DMSO
  4. BI 2536
    A3965 BI 2536
     1 Citation
    Target: PLK|Bromodomain-containing proteins(BRDs)
    Summary: Plk1 inhibitor,potent and ATP-competitive
      insoluble in H2O; ≥13.04 mg/mL
  5. Empagliflozin (BI 10773)
    A4601 Empagliflozin (BI 10773)
     2 Citation
    Summary: SGLT-2 inhibitor for oral treatment of type 2 diabetes
      insoluble in H2O; ≥20.75 mg/mL
  6. Anti-SIRPa/CD172a Antibody (BI 765063)
    F1821 Anti-SIRPa/CD172a Antibody (BI 765063)
    Summary: Anti-SIRPa/CD172a Antibody (BI 765063)
  7. Olmutinib (HM61713, BI 1482694)
    B7813 Olmutinib (HM61713, BI 1482694)
    Summary: EGFR mutant-specific inhibitor
  8. Monomethyl auristatin E
    A3631 Monomethyl auristatin E
    Summary: A type of antimitotic agent that can also be widely used as a cytotoxic component for the preparation of antibody-drug conjugates (ADCs) for cancer research.
      ≥35.9 mg/mL
  9. Vipoglanstat
    BA6166 Vipoglanstat
    Summary: Vipoglanstat (BI1029539), formamide, is a potent, selective, nonpeptide human prostaglandin E synthase 1 small molecule inhibitor with oral activity.
  10. Bevurogant
    BA8326 Bevurogant
    Summary: Bevurogant (BI730357) is a retinol-related orphan receptor-γt antagonist.

Items 1-10 of 136

Page
per page